Clinical Trial Update: Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells in patients with Multiple Sclerosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Allogeneic Umbilical Cord Mesenchymal Stem Cells (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Ever Supreme Bio Technology Co., Ltd. | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: RECRUITING